Dr. Pruitt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4230 Harding Road
Suite 309 Medical Plaza West
Nashville, TN 37205Phone+1 615-383-0165Fax+1 615-292-4657
Summary
- I am double board certified in Internal Medicine and Gastroenterology/Hepatology with advanced endoscopic training and skills in therapeutic ERCP and ablation/EMR of Barrett's esophagus...I have the greatest case load in our region with these procedures. I have extensive experience in direct patient care as well as clinical research (conducted over 400 clinical trials). I have authored numerous publications and received several awards and honors during the course of my 30+ year career. For the last few years I have focused an additional interest on SUD, having opened 2 free standing, high acuity medical detox facilities with 2 additional ones under development.
Education & Training
- University of Alabama Medical CenterFellowship, Gastroenterology, 1987 - 1989
- University of Alabama Medical CenterResidency, Internal Medicine, 1984 - 1987
- University of North Carolina at Chapel Hill School of MedicineClass of 1984
Certifications & Licensure
- TN State Medical License 1989 - 2026
- NC State Medical License 1985 - 2017
- AL State Medical License 1985 - 1992
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
- National Board of Physicians and Surgeons Gastroenterology
- National Board of Physicians and Surgeons Internal Medicine
Awards, Honors, & Recognition
- Fellow (FACP) American College of Physicians
- Fellow (FACG) American College of Gastroenterology
- Best Research Paper in Biliary Lithotripsy American Lithotripsy Association, 1989
- Join now to see all
Clinical Trials
- Merimepodib (MMPD) in Triple Combination for the Treatment of Chronic Hepatitis C Start of enrollment: 2004 Jul 01
- YM443 in Subjects With Functional Dyspepsia Start of enrollment: 2004 Mar 10
- Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin for the Treatment of Hepatitis C Start of enrollment: 2007 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 41 citationsSafety and efficacy of a new 3.3 g b.i.d. tablet formulation in patients with mild-to-moderately-active ulcerative colitis: a multicenter, randomized, double-blind, pl...Ellen Scherl, Ronald E. Pruitt, Glenn L. Gordon, Mark Lamet, Audrey L. Shaw
The American Journal of Gastroenterology. 2009-06-01 - 223 citationsA Phase 2 Study of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients With Crohn’s DiseaseWilliam J. Sandborn, Subrata Ghosh, Julián Panés, Ivana Vranic, Wenjin Wang
Clinical Gastroenterology and Hepatology. 2014-09-01 - 139 citationsA phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy.Douglas K. Rex, Raj Bhandari, Taddese Desta, Michael P. DeMicco, Cynthia Schaeffer
Gastrointestinal Endoscopy. 2018-09-01
Professional Memberships
- Fellow
- Fellow
- Fellow
External Links
- Nashville GI Speciailistshttp://NashvilleGi.com
- Saint Thomas Medical Grouphttp://STMG.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: